title: [Adherence to long-term medication: the particular case of the adjuvant endocrine therapy for breast cancer].
abstract: The aim of adjuvant hormone therapy for breast cancer is to reach, in daily practice, an efficacy similar to that obtained in clinical trials. In spite of the demonstrated efficacy of hormone therapy, compliance represents a major challenge and a multidimensional problem. A better understanding of the reasons underlying non-compliance would help identify the patients at higher risk and would permit the implementation of strategies to improve compliance to adjuvant hormone therapy. With this in mind, we undertook a review of the recent literature on the topic (Pub Med 2003-2009).
authors.affiliation: Service de Sénologie, CHU de Liège, Belgique.
authors.forename: V
authors.initials: V
authors.lastname: Bleret
authors.forename: J
authors.initials: J
authors.lastname: Collignon
authors.forename: Ph
authors.initials: P
authors.lastname: Coucke
authors.forename: P
authors.initials: P
authors.lastname: Cusumano
authors.forename: J
authors.initials: J
authors.lastname: Desreux
authors.forename: Ph
authors.initials: P
authors.lastname: Herman
authors.forename: G
authors.initials: G
authors.lastname: Jerusalem
authors.forename: S
authors.initials: S
authors.lastname: Maweja
authors.forename: N
authors.initials: N
authors.lastname: Remacle
authors.forename: A
authors.initials: A
authors.lastname: Rorive
authors.forename: E
authors.initials: E
authors.lastname: Lifrange
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D055118:Medication Adherence; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal